Enhabit (NYSE:EHAB) Stock Rating Upgraded by TD Cowen

Enhabit (NYSE:EHAB) was upgraded by research analysts at TD Cowen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. The brokerage presently has a $12.00 target price on the stock. TD Cowen’s target price suggests a potential upside of 17.91% from the stock’s previous close.

Other analysts have also recently issued research reports about the company. Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Wolfe Research set a $12.00 price target on Enhabit in a report on Thursday. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. UBS Group raised shares of Enhabit from a “neutral” rating to a “buy” rating and raised their price objective for the company from $8.50 to $12.00 in a research report on Thursday. Finally, Citigroup reissued a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Five analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $11.63.

Enhabit Stock Performance

Shares of EHAB opened at $10.18 on Tuesday. The company has a market capitalization of $515.03 million, a PE ratio of -40.71 and a beta of 1.66. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. The company’s 50 day moving average price is $9.05 and its 200 day moving average price is $8.21. Enhabit has a 52 week low of $6.47 and a 52 week high of $10.90.

Enhabit (NYSE:EHAB) last released its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. The company had revenue of $263.60 million during the quarter, compared to the consensus estimate of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Research analysts expect that Enhabit will post 0.22 EPS for the current fiscal year.

Institutional Trading of Enhabit

A number of institutional investors and hedge funds have recently modified their holdings of the company. SG Americas Securities LLC acquired a new position in Enhabit in the 4th quarter valued at $180,000. Verition Fund Management LLC bought a new stake in Enhabit during the third quarter valued at about $228,000. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Enhabit in the third quarter valued at about $95,000. Bank of America Corp DE increased its stake in shares of Enhabit by 73.3% in the third quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock worth $5,510,000 after purchasing an additional 290,978 shares during the period. Finally, 8 Knots Management LLC lifted its position in shares of Enhabit by 9.5% during the 3rd quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company’s stock worth $33,793,000 after purchasing an additional 365,779 shares during the last quarter.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.